DANIEL KIERNAN: Open Payments
NPI 1992308811 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 29 payments from 13 companies in 2025. Trend: 2023 $1,188 · 2024 $1,124 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $262 |
| PFIZER INC. | 8 | $224 |
| SCPHARMACEUTICALS INC. | 1 | $102 |
| Boston Scientific Corporation | 2 | $75 |
| LANTHEUS MEDICAL IMAGING, INC. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $20 |
Products named: LifeVest, VYNDAQEL, FUROSCIX, ELIQUIS, DEFINITY, LEQVIO, JARDIANCE, REPATHA.
Industry payments across VA — which companies pay providers there.
